Marimed (MRMD) Revenue Growth (1y) (2012 - 2026)
Marimed (MRMD) Revenue Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.56 Bn | 12.13 Bn | 785.00 Mn | 14.92% |
| 10 | Marimed | 25.72 Mn | 17.78 Mn | 15.28 Mn | 4.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.16% |
| Dec 31, 2025 | 6.93% |
| Sep 30, 2025 | 0.42% |
| Jun 30, 2025 | -2.05% |
| Mar 31, 2025 | -0.07% |
| Dec 31, 2024 | 0.13% |
| Sep 30, 2024 | 4.63% |
| Jun 30, 2024 | 10.73% |
| Mar 31, 2024 | 10.33% |
| Dec 31, 2023 | 8.57% |
| Sep 30, 2023 | 14.41% |
| Jun 30, 2023 | 10.71% |
| Mar 31, 2023 | 9.90% |
| Dec 31, 2022 | 15.42% |
| Sep 30, 2022 | 2.12% |
| Jun 30, 2022 | 1.28% |
| Mar 31, 2022 | 26.94% |
| Dec 31, 2021 | 52.50% |
| Sep 30, 2021 | 146.69% |
| Jun 30, 2021 | 238.90% |